Mobile Menu

Basic Pharmaceutical Product Manufacturing in Ireland - Market Research Report (2014-2029)

Martha Garcia Guerrero Martha Garcia Guerrero London, United Kingdom Last Updated: April 2024 SIC C21.100IE

Revenue

€16.7bn

2024

€16.7bn

Past 5-Year Growth

Profit

€X.Xbn

Employees

4,605

Businesses

97

Wages

€XXX.Xm

Basic Pharmaceutical Product Manufacturing in Ireland industry analysis

Demand for Active Pharmaceutical Ingredients (APIs)  and other pharmaceutical substances produced by the Basic Pharmaceutical Product Manufacturing industry depends on consumer demand for pharmaceutical products. Over the past few years, an ageing Irish population has bolstered demand for pharmaceutical products, as pharmaceutical treatments for degenerative illnesses have become more popular. Rising obesity levels and associated health conditions, like diabetes, have also lifted demand for pharmaceuticals. Industry revenue is anticipated to climb at a compound annual rate of 5.9% over the five years through 2024, including a forecast growth of 2.9% in 2024, to reach €16.7 billion. Over the two years through 2021, pharmaceutical product manufacturers' demand benefitted from the COVID-19 outbreak, as APIs were used in COVID-19 vaccine trials and antibody tests collected using blood sampling. Although revenue from COVID-19-related products is in sharp decline in 2024, the high diversification of the industry means industry revenue will continue to grow regardless.

Trends and Insights

  • Ireland’s ageing population is boosting the industry. As people age, they’re more likely to develop chronic illnesses and require medical intervention. Growth in the number of people aged 65 years and over is boosting demand for basic pharmaceutical products.
  • Irish API manufacturers have expanded their repertoires in recent years. This has supported this segment’s share of revenue in the industry. Their importance for the development of COVID-19 vaccines has also boosted the industry.
  • Dublin is a popular place for manufacturers to set up shop. This is down to the easy access to the graduate workforce and Dublin being home to most hospitals and teaching institutions, encouraging pharmaceutical manufacturers to operate near these facilities.
  • Market share concentration is low. This is down to the industry’s size and the number of international pharmaceutical giants in the mix. Although, Pfizer’s market share has been on the rise since its successful manufacture of the COVID-19 vaccine.

Access hundreds of analysis and data

  • Market estimates from 2014-2029
  • Critical performance data and rankings
  • Detailed analysis of competitive forces and the external environment
  • PDF report or online database with Word, Excel and PowerPoint export options
  • 100% money back guarantee

Industry Statistics and Trends

Market size and recent performance (2014-2029)

Industry revenue has grown at a CAGR of 5.9 % over the past five years, to reach an estimated €16.7bn in 2024.

Trends and Insights

Ireland’s ageing population has aided industry demand over the past few years

  • As people get older, they’re more likely to develop chronic illnesses and require medical intervention.
  • Additional trends and insights available with purchase
Basic Pharmaceutical Product Manufacturing in Ireland
Revenue (2014-2029)
IBISWorld Logo Source: IBISWorld

Industry outlook (2024-2029)

Market size is projected to grow over the next five years.

Trends and Insights

A higher global tax rate is unlikely to hinder revenue growth in Ireland

  • Ireland's low 12.5% corporation tax has lured many manufacturers into Ireland. However, the G7 group agreed that the profit of companies with a combined annual turnover of at least €750 million will be taxed at a minimum rate of 15% by 2024.

Biggest companies in the Basic Pharmaceutical Product Manufacturing in Ireland

Company
Market Share (%)
2024
Revenue (€m)
2024
Eli Lilly and Company
13,978.0
Pfizer Healthcare Ireland
1,213.6
Janssen Sciences Ireland Unlimited Company
471.3

To view the market share and analysis for all 6 top companies in this industry, view purchase options.

Products & Services Segmentation

Basic Pharmaceutical Product Manufacturing in Ireland
Products & Services
IBISWorld Logo Source: IBISWorld

Industry revenue is measured across several distinct product and services lines, including Active pharmaceutical ingredients, Human and animal blood processing and Manufacture of other pharmaceutical products. Active pharmaceutical ingredients is the largest segment of the Basic Pharmaceutical Product Manufacturing in Ireland.

Trends and Insights

Growing medical needs and new medical developments support API’s demand

  • APIs are the biologically active components in medications responsible for producing the desired therapeutic effects. APIs are used to make most medicines (e.g. antibiotics and aspirin), develop drugs and conduct clinical trials.
  • More insights available in the full report

Table of Contents

About this industry

Industry definition

Companies in the Basic Pharmaceutical Product Manufacturing industry manufacture medicinal active substances that are used for their pharmacological properties to make medications, including antibiotics, basic vitamins, salicylic acids and aspirin. The industry also includes companies that process blood and glands and manufacture chemically pure sugars.

What's included in this industry?

Active pharmaceutical ingredientsHuman and animal blood processingManufacture of extracts from glands and hormonesManufacture of chemically pure sugars and salts

Companies

Eli Lilly and CompanyPfizer Healthcare IrelandJanssen Sciences Ireland Unlimited Company

Purchase this report to view all 6 major companies in this industry.

Related Terms

GENERIC DRUGACTIVE PHARMACEUTICAL INGREDIENT (API)BIOPHARMACEUTICALSPRECISION MEDICINECHROMATOGRAPHY

Industry Code

SIC 2007

SIC 21.10 - Basic Pharmaceutical Product Manufacturing in Ireland

Performance

Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.

Analyst insights

Ireland’s ageing population is boosting the industry. As people age, they’re more likely to develop chronic illnesses and require medical intervention. Growth in the number o...

In this chapter (4)

  • Current Performance
  • Outlook
  • Volatility
  • Life Cycle

Key metrics

  • Annual Revenue, Recent Growth, Forecast, Revenue Volatility
  • Number of Employees, Recent Growth, Forecast, Employees per Business, Revenue per Employee
  • Number of Businesses, Recent Growth, Forecast, Employees per Business, Revenue per Business
  • Total Profit, Profit Margin, Profit per Business

Charts

  • Revenue, including historical (2014-2023) and forecast (2024-2029)
  • Employees, including historical (2014-2023) and forecast (2024-2029)
  • Businesses, including historical (2014-2023) and forecast (2024-2029)
  • Profit, including historical (2014-2024)
  • Industry Volatility vs. Revenue Growth
  • Industry Life Cycle

Detailed analysis

  • Trends in supply, demand and current events that are driving current industry performance
  • Expected trends, economic factors and ongoing events that drive the industry's outlook
  • Key success factors for businesses to overcome volatility
  • How contribution to GDP, industry saturation, innovation, consolidation, and technology and systems influence the industry's life cycle phase.

Products and Markets

Learn about an industry's products and services, markets and trends in international trade.

Analyst insight

Irish API manufacturers have expanded their repertoires in recent years. This has supported this segment’s share of revenue in the industry. Their importance for the developm...

In this chapter

  • Products & Services
  • Major Markets
  • International Trade

Key metrics

  • Largest market segment and value in 2024
  • Product innovation level
  • Total imports, level and trend
  • Total exports, level and trend
  • Trade Balance

Charts

  • Products & services segmentation in 2024
  • Major market segmentation in 2024
  • International trade, including imports by country and exports by country

Detailed analysis

  • Trends impacting the recent performance of the industry's various segments
  • Innovations in the industry's product or service offering, specialization or delivery method
  • Key factors that successful businesses consider in their offerings
  • Buying segments and key trends influencing demand for industry products and services
  • Recent trends in import and export volumes, country of origin or destination, and expected future trends

Geographic Breakdown

Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.

Analyst insights

Dublin is a popular place for manufacturers to set up shop. This is down to the easy access to the graduate workforce and Dublin being home to most hospitals and teaching ins...

In this chapter (1)

  • Business Locations

Charts

  • Share of revenue, establishment, wages and employment in each region
  • Share of population compared to establishments in each region in 2024

Tables

  • Number and share of establishments in each region in 2024
  • Number and share of revenue each region accounts for in 2024
  • Number and share of wages each region accounts for in 2024
  • Number and share of employees in each region in 2024

Detailed analysis

  • Geographic spread of the industry across Europe, and trends associated with changes in the business landscape
  • Key success factors for businesses to use location to their advantage

Competitive Forces

Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.

Analyst insights

Market share concentration is low. This is down to the industry’s size and the number of international pharmaceutical giants in the mix. Although, Pfizer’s market share has b...

In this chapter (4)

  • Concentration
  • Barriers to Entry
  • Substitutes
  • Buyer & Supplier Analysis

Key metrics

  • Industry concentration level
  • Industry competition level and trend
  • Barriers to entry level and trend
  • Substitutes level and trend
  • Buyer power level and trend
  • Supplier power level and trend

Charts

  • Market share concentration among the top 4 suppliers from 2019-2024
  • Supply chain including upstream supplying industries and downstream buying industries, flow chart

Detailed analysis

  • Factors impacting the industry’s level of concentration, such as business distribution, new entrants, or merger and acquisition activity.
  • Key success factors for businesses to manage the competitive environment of the industry.
  • Challenges that potential industry entrants face such as legal, start-up costs, differentiation, labor/capital intensity and capital expenses.
  • Key success factors for potential entrants to overcome barriers to entry.
  • Competitive threats from potential substitutes for the industry’s own products and services.
  • Key success factors for how successful businesses can compete with substitutes.
  • Advantages that buyers have to keep favorable purchasing conditions.
  • Advantages that suppliers have to maintain favorable selling conditions.
  • Key success factors for how businesses can navigate buyer and supplier power.

Companies

Learn about the performance of the top companies in the industry.

Analyst insights

Some players are becoming increasingly environmentally friendly. This helps companies like Eli Lilly and Company reduce their energy expenditure and boost profit, all while h...

In this chapter

  • Market Share Concentration
  • Companies
  • Company Spotlights

Charts

  • Industry market share by company in 2020 through 2024
  • Major companies in the industry, including market share, revenue, profit and profit margin in 2024
  • Overview of Eli Lilly and Company's performance by revenue, market share and profit margin from 2018 through 2024
  • Overview of Pfizer Healthcare Ireland's performance by revenue, market share and profit margin from 2018 through 2024
  • Overview of Janssen Sciences Ireland Unlimited Company's performance by revenue, market share and profit margin from 2018 through 2024
  • Overview of revenue, market share and profit margin trend for 3 additional companies

Detailed analysis

  • Description and key data for Eli Lilly and Company, and factors influencing its performance in the industry
  • Description and key data for Pfizer Healthcare Ireland, and factors influencing its performance in the industry
  • Description and key data for Janssen Sciences Ireland Unlimited Company, and factors influencing its performance in the industry
  • Description, key data and performance trends for 3 additional companies

External Environment

Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.   

Analyst insights

Public healthcare expenditure impacts basic pharmaceutical manufacturers’ demand. When more money is pumped into public healthcare, demand for pharmaceutical products general...

In this chapter

  • External Drivers
  • Regulation & Policy
  • Assistance

Key metrics

  • Regulation & policy level and trend
  • Assistance level and trend

Charts

  • Regulation & Policy historical data and forecast (2014-2029) 
  • Assistance historical data and forecast (2014-2029) 

Detailed analysis

  • Demographic and macroeconomic factors influencing the industry, including Regulation & Policy and Assistance
  • Major types of regulations, regulatory bodies, industry standards or specific regulations impacting requirements for industry operators
  • Key governmental and non-governmental groups or policies that may provide some relief for industry operators.

Financial Benchmarks

View average costs for industry operators and compare financial data against an industry's financial benchmarks over time. 

Analyst insights

Profit remains strong. Pharmaceutical companies’ profits have remained strong despite increased costs and geopolitical disruptions, mainly due to the heightened demand for ph...

In this chapter

  • Cost Structure
  • Financial Ratios
  • Key Ratios

Key metrics

  • Profit margin, and how it compares to the sector-wide margin
  • Average wages, and how it compares to the sector-wide average wage
  • Largest cost component as a percentage of revenue
  • Industry average ratios for days' receivables, industry coverage and debt-to-net-worth ratio

Charts

  • Average industry operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
  • Average sector operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
  • Investment vs. share of economy

Data tables

  • Cash Flow & Debt Service Ratios (2014-2029)
  • Revenue per Employee (2014-2029)
  • Revenue per Enterprise (2014-2029)
  • Employees per Establishment (2014-2029)
  • Employees per Enterprise (2014-2029)
  • Average Wage (2014-2029)
  • Wages/Revenue (2014-2029)
  • Establishments per Enterprise (2014-2029)
  • IVA/Revenue (2014-2029)
  • Imports/Demand (2014-2029)
  • Exports/Revenue (2014-2029)

Detailed analysis

  • Trends in the cost component for industry operators and their impact on industry costs and profitability 

Key Statistics

Industry Data

Data Tables

Including values and annual change:

  • Revenue (2014-2029)
  • IVA (2014-2029)
  • Establishments (2014-2029)
  • Enterprises (2014-2029)
  • Employment (2014-2029)
  • Exports (2014-2029)
  • Imports (2014-2029)
  • Wages (2014-2029)

Top Questions Answered

Unlock comprehensive answers and precise data upon purchase. View purchase options.

What is the market size of the Basic Pharmaceutical Product Manufacturing industry in Ireland in 2024?

The market size of the Basic Pharmaceutical Product Manufacturing industry in Ireland is €16.7bn in 2024.

How many businesses are there in the Basic Pharmaceutical Product Manufacturing in Ireland industry in 2024?

There are 97 businesses in the Basic Pharmaceutical Product Manufacturing industry in Ireland, which has grown at a CAGR of 4.7 % between 2019 and 2024.

Has the Basic Pharmaceutical Product Manufacturing industry in Ireland grown or declined over the past 5 years?

The market size of the Basic Pharmaceutical Product Manufacturing industry in Ireland has been growing at a CAGR of 5.9 % between 2019 and 2024.

What is the forecast growth of the Basic Pharmaceutical Product Manufacturing industry in Ireland over the next 5 years?

Over the next five years, the Basic Pharmaceutical Product Manufacturing industry in Ireland is expected to grow.

What are the biggest companies in the Basic Pharmaceutical Product Manufacturing market in Ireland?

The biggest companies operating in the Basic Pharmaceutical Product Manufacturing market in Ireland are Eli Lilly and Company, Pfizer Healthcare Ireland and Janssen Sciences Ireland Unlimited Company

What does the Basic Pharmaceutical Product Manufacturing in Ireland include?

Active pharmaceutical ingredients and Human and animal blood processing are part of the Basic Pharmaceutical Product Manufacturing industry.

Which companies have the highest market share in the Basic Pharmaceutical Product Manufacturing in Ireland?

The company holding the most market share in Ireland is Eli Lilly and Company.

How competitive is the Basic Pharmaceutical Product Manufacturing industry in Ireland?

The level of competition is high and steady in the Basic Pharmaceutical Product Manufacturing industry in Ireland.

Related Industries

Widen your competitive advantage with related industries

Competitors

  • There are no industries to display.

Complementors

  • Pharmaceutical Preparations Manufacturing in Ireland
  • Pharmaceutical Wholesaling in Ireland
  • Dispensing Chemists in Ireland

International industries

  • Pharmaceutical Product Manufacturing in Australia
  • Basic Pharmaceutical Product Manufacturing in the UK
  • Pharmaceutical Raw Material Manufacturing in China
  • Biological and Biochemical Product Manufacturing in China

View all industries in Ireland

Methodology

How are IBISWorld reports created?

IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.

Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.

IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.

What data sources do IBISWorld analysts use?

Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.

Key data sources in Ireland include:

  • Central Statistics Office
  • Department of Enterprise, Trade and Employment
  • Irish Tax & Customs

Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.

These sources include:

  • Industry and trade associations
  • Industry federations or regulators
  • Major industry players annual or quarterly filings

Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.

How does IBISWorld forecast its data?

IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.

IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.

Learn more about our methodology and data sourcing on the Help Center.